As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances in diagnosis and treatment.

Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated ...

Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...

Novel multiomics tumor profiling demonstrates feasibility and clinical benefit in guiding melanoma treatment decisions, a ...

Tumor markers are made by cancer cells or produced by the body in response to cancer. Learn about common markers for pancreatic cancer and how they're used.

Tumor markers can be employed for screening, diagnosis, prognostication, guiding therapy, as well as post-therapy surveillance. However, laboratorians need to consider sensitivity, specificity, ...

The public health system in England offered me palliative care. It was a death sentence I wasn't willing to accept. I wasn't ready to leave behind my six children: Matt, 35; Will, 24; Hannah, 19; ...

A team from Nagoya University in Japan has identified a new tumor marker for early detection of cancer. The diagnostic performance of the marker showed a greater performance than that of current ...

Disseminated tumor cells need to re-express their epithelial properties via the MET to form tumor cell clusters (micrometastases).

In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

Since Henry Bence Jones first discovered a urine protein marker for multiple myeloma in 1846, the field of cancer biomarkers has grown exponentially. Over the past two centuries, scientists have ...